BP000429-HIV-111: Recombinant HIV-1 gag p17,p24, gp120
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000429-HIV-121: Recombinant HIV-1 gag p17, p24
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.
Applications: WB, ELISA.BP000429-HIV-110: Recombinant HIV-1 gag p17-p24, gp41-gp120
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000428-HIV-152: Recombinant HIV-1 Envelope, His Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000428-HIV-101: Recombinant HIV-1 Envelope
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000427-HIV-132: Recombinant HIV Type-O Envelope
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000427-HIV-133: Recombinant HIV Type-O gp41
Source: E. coli-derived.
Purity > 90%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000427-HIV-143: Recombinant HIV Type-O gp41, Maltose Binding Protein tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000207-CYT-090: Recombinant Human Hepatocyte Growth Factor (HGF), HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of the monkey epithelial cell line 4MBr-5 and is typically 10-50 ug/ml.
Purity > 95%, by SDS-PAGE.BP000207-CYT-244: Recombinant Human Hepatocyte Growth Factor (HGF)
Source: Insect cells-derived.
The activity was assayed for scattering activity in the MDCK cell assay. The ED50 for this effect is typically at 2.0-5.0 ug/ml (200,000-500,000 U/mg).
Purity > 90%, by SDS-PAGE.